knowledge -WSS

knowledge

author：comprehensive 2025-10-02 23:30:15 - browse：16

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

Advisers to the Food and Drug Administration voted 11-0 on Monday to recommend the approval of a drug for early Alzheimer’s disease made by Eli Lilly — ruling that the treatment’s ability to slow the cognitive decline in patients outweighed its safety risks.

The unanimous outcome of the daylong advisory panel was the best-case scenario for Lilly, making it likely that the FDA will approve the drug, called donanemab, for a broad population of people diagnosed with mild cognitive impairment due to Alzheimer’s. A decision is expected later this year.

“The benefits outweigh the risks, as long as the risks are being monitored,” said Kathleen Poston, a neurologist at Stanford University and a member of the advisory panel.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Novartis develops a rapidly manufactured CAR

focus

leisure time

WSS

Malaysia cuts short music fest after British band slams anti

Organ aging and disease risk measured by new blood test

The response to Covid

The response to Covid

Despite FDA concern, risk that CAR

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

hotspot

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

4 missing after record

Novavax promises a turnaround & Lilly roils the obesity market

Hundreds of thousands march in Israel. Former security chiefs beg Netanyahu to halt legal overhaul

New air purifier tech could be key to improving indoor air quality

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

Wildfire smoke exposes gaps in outdoor worker protections

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA approves first blood sugar monitor without finger pricks

Wikipedia

Malaysia cuts short music fest after British band slams anti

ReNAgade cuts staff seven months after raising $300 million

What to do when lifesaving products contribute to climate change

My chronic pain journey would have been easier knowing 5 things % STAT

FDA investigates CAR

UnitedHealth’s Optum accused of antitrust violations in California

focus

leisure time

Wikipedia

entertainment